{
  "id": 6315736,
  "title": "Specific CAR T-cell subgroup could make lower-dose cancer therapy more effective",
  "url": "https://urgent.news/2026/09/08/specific-car-t-cell-subgroup-could-make-lower-dose-cancer-therapy",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-08T19:00:02.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-09-specific-car-cell-subgroup-dose.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Immunotherapies strengthen the body's own anticancer defenses in a highly targeted manner. In therapies using so-called CAR T cells (chimeric antigen receptor T cells), a patient's immune cells are genetically engineered and directed against individual cancer cells. Until now, it has remained unclear why even very low CAR T-cell doses are effective in some patients while others do not benefit…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "Amgen’s T-cell engager notches major new lung cancer victory",
        "url": "https://urgent.news/2026/09/08/amgens-t-cell-engager-notches-major-new-lung-cancer-victory",
        "published": "2026-09-08T17:53:52.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}